Adolescent; Adult; Antibodies, Viral; Antibody Formation; BNT162 Vaccine; Child; COVID-19; COVID-19 Vaccines; Humans; SARS-CoV-2; Young Adult; biological product; bnt 162b 2; immunosuppressive agent; steroid; tozinameran; virus spike protein; virus antibody; anaphylaxis; antibody response; antibody titer; arthralgia; Article; bloody diarrhea; chill; chromosome aberration; congenital malformation; controlled study; coronavirus disease 2019; drug safety; electronic medical record; endocrine disease; face pain; fatigue; female; fever; genetic disorder; headache; human; immunocompromised patient; major clinical study; male; metabolic disorder; myalgia; observational study; prospective study; questionnaire; receptor binding; thorax pain; vaccination; vomiting; adverse event; antibody production; prevention and control; Immunization; mRNA